Evolent Health Inc (NYSE:EVH) has a beta value of 1.44 and has seen 0.87 million shares traded in the recent trading session. The company, currently valued at $1.27B, closed the recent trade at $10.89 per share which meant it gained $0.02 on the day or 0.18% during that session. The EVH stock price is -221.4% off its 52-week high price of $35.00 and 1.74% above the 52-week low of $10.70. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.88 million shares traded. The 3-month trading volume is 2.53 million shares.
The consensus among analysts is that Evolent Health Inc (EVH) is Buy stock at the moment, with a recommendation rating of 1.14. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 5 have rated it as a Hold, with 5 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.05.
Evolent Health Inc (NYSE:EVH) trade information
Sporting 0.18% in the green today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the EVH stock price touched $10.89 or saw a rise of 8.33%. Year-to-date, Evolent Health Inc shares have moved -67.03%, while the 5-day performance has seen it change -8.87%. Over the past 30 days, the shares of Evolent Health Inc (NYSE:EVH) have changed -11.82%. Short interest in the company has seen 10.51 million shares shorted with days to cover at 3.1.
Wall Street analysts have a consensus price target for the stock at $33, which means that the shares’ value could jump 67.0% from the levels at last check today. The projected low price target is $28.0 while the price target rests at a high of $38.0. In that case, then, we find that the latest price level in today’s session is -248.94% off the targeted high while a plunge would see the stock gain -157.12% from the levels at last check today.
Evolent Health Inc (EVH) estimates and forecasts
Figures show that Evolent Health Inc shares have underperformed across the wider relevant industry. The company’s shares have lost -50.57% over the past 6 months, with this year growth rate of -16.09%, compared to 25.70% for the industry. Revenue growth from the last financial year stood is estimated to be 30.34%.
14 analysts offering their estimates for the company have set an average revenue estimate of 652.18M for the current quarter. 10 have an estimated revenue figure of 714.95M for the next ending quarter. Year-ago sales stood 556.05M and 639.65M respectively for this quarter and the next, and analysts expect sales will grow by 17.29% for the current quarter and 30.34% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -13.43% over the past 5 years. Earnings growth for 2024 is a modest -28.91% while over the next 5 years, the company’s earnings are expected to increase by 30.00%.
EVH Dividends
Evolent Health Inc is expected to release its next earnings report in January this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Evolent Health Inc (NYSE:EVH)’s Major holders
Insiders own 3.95% of the company shares, while shares held by institutions stand at 115.78% with a share float percentage of 120.54%. Investors are also buoyed by the number of investors in a company, with Evolent Health Inc having a total of 370.0 institutions that hold shares in the company. The top two institutional holders are WELLINGTON MANAGEMENT GROUP LLP with over 11.17 million shares worth more than $213.55 million. As of 2024-06-30, WELLINGTON MANAGEMENT GROUP LLP held 9.785% of shares outstanding.
The other major institutional holder is VANGUARD GROUP INC, with the holding of over 11.06 million shares as of 2024-06-30. The firm’s total holdings are worth over $211.39 million and represent 9.6862% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Specialized-Health Care Fund and Vanguard Total Stock Market Index Fund. As of Jul 31, 2024, the former fund manager holds about 4.94% shares in the company for having 5.76 shares of worth $62.8 million while later fund manager owns 3.48 shares of worth $37.97 million as of Sep 30, 2024, which makes it owner of about 2.99% of company’s outstanding stock.
